Miaomiao Xue1, Qingmiao Shi2, Lian Zheng3, Qingbin Li3, Liya Yang1, Yuanyuan Zhang1. 1. Department of General Dentistry, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan, P. R. China. 2. Gene Hospital of Henan Province, Precision Medicine Center, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan, P. R. China. 3. Department of Oral and Maxillofacial Surgery, The First Affiliated Hospital of Zhengzhou University Zhengzhou 450052, Henan, P. R. China.
Abstract
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the fifth most common malignancy in the world. The 5-methylcytosine (m5C) plays vital roles in pathological conditions, such as cancer. METHODS: This study investigated The Cancer Genome Atlas (TCGA) database for patients with HNSCC. We characterized the mutations and copy number variations (CNVs) in m5C-regulatory genes, in addition to analyzing their mRNA expressions. Gene set enrichment analysis (GSEA) and protein-protein interaction (PPI) analyses were used to explore relevant functional annotations of m5C-regulatory genes. RESULTS: Alterations in m5C-regulatory genes were closely associated with patient clinicopathological characteristics. The expression of ten m5C-regulatory genes was significantly correlated with CNV patterns, indicating that m5C-regulatory genes have important regulatory effects. There was increased expression of m5C-regulatory genes, particularly ALYREF and NSUN5, during the tumor, node, and metastasis stages. Cox regression analysis revealed that the expression of DNMT1, TET2, and NSUN6 correlated with HNSCC prognoses. Furthermore, the expression of DNMT1 and ALYREF could effectively predict HNSCC risk in patients. In addition, the high expression levels of ALYREF correlated with mitochondrial function, and the elevated DNMT1 expression was associated with peptide cross-linking and humoral immunity. These results provide promising insight into the roles of m5C genes in tumor energy-metabolism and protein synthesis. CONCLUSIONS: Collectively, the results indicate that m5C plays critical roles in HNSCC progression, and is also a potential HNSCC prognostic marker. AJTR
BACKGROUND: Head and neck squamous cell carcinoma (HNSCC) is the fifth most common malignancy in the world. The 5-methylcytosine (m5C) plays vital roles in pathological conditions, such as cancer. METHODS: This study investigated The Cancer Genome Atlas (TCGA) database for patients with HNSCC. We characterized the mutations and copy number variations (CNVs) in m5C-regulatory genes, in addition to analyzing their mRNA expressions. Gene set enrichment analysis (GSEA) and protein-protein interaction (PPI) analyses were used to explore relevant functional annotations of m5C-regulatory genes. RESULTS: Alterations in m5C-regulatory genes were closely associated with patient clinicopathological characteristics. The expression of ten m5C-regulatory genes was significantly correlated with CNV patterns, indicating that m5C-regulatory genes have important regulatory effects. There was increased expression of m5C-regulatory genes, particularly ALYREF and NSUN5, during the tumor, node, and metastasis stages. Cox regression analysis revealed that the expression of DNMT1, TET2, and NSUN6 correlated with HNSCC prognoses. Furthermore, the expression of DNMT1 and ALYREF could effectively predict HNSCC risk in patients. In addition, the high expression levels of ALYREF correlated with mitochondrial function, and the elevated DNMT1 expression was associated with peptide cross-linking and humoral immunity. These results provide promising insight into the roles of m5C genes in tumor energy-metabolism and protein synthesis. CONCLUSIONS: Collectively, the results indicate that m5C plays critical roles in HNSCC progression, and is also a potential HNSCC prognostic marker. AJTR
Authors: Jixi Li; Kang Liu; Tingting Zhang; Zhendong Yang; Rensheng Wang; Gang Chen; Min Kang Journal: Am J Transl Res Date: 2018-08-15 Impact factor: 4.060
Authors: Muzammil Ahmad Khan; Muhammad Arshad Rafiq; Abdul Noor; Shobbir Hussain; Joana V Flores; Verena Rupp; Akshita K Vincent; Roland Malli; Ghazanfar Ali; Falak Sher Khan; Gisele E Ishak; Dan Doherty; Rosanna Weksberg; Muhammad Ayub; Christian Windpassinger; Shahnaz Ibrahim; Michaela Frye; Muhammad Ansar; John B Vincent Journal: Am J Hum Genet Date: 2012-04-26 Impact factor: 11.025
Authors: Ezra E W Cohen; R Bryan Bell; Carlo B Bifulco; Barbara Burtness; Maura L Gillison; Kevin J Harrington; Quynh-Thu Le; Nancy Y Lee; Rom Leidner; Rebecca L Lewis; Lisa Licitra; Hisham Mehanna; Loren K Mell; Adam Raben; Andrew G Sikora; Ravindra Uppaluri; Fernanda Whitworth; Dan P Zandberg; Robert L Ferris Journal: J Immunother Cancer Date: 2019-07-15 Impact factor: 13.751